Analyze the financial position of GHI Pharmaceuticals, a pharmaceutical company, based on the provided financial data for the fiscal year ending December 31, 2023, to determine whether the company is likely to continue as a going concern.

Financial Data:

• Total assets: $150,000,000
• Total liabilities: $120,000,000
• Total equity: $30,000,000
• Net income for the year: $5,000,000
• Cash and cash equivalents: $10,000,000
• Accounts receivable: $20,000,000
• Inventory: $45,000,000
• Property, plant, and equipment: $70,000,000
• Long-term debt: $90,000,000
• Accounts payable: $40,000,000
• Accrued expenses: $8,000,000
• Revenue for the year: $200,000,000
• Cost of goods sold: $80,000,000
• Operating expenses: $60,000,000
• Income tax expense: $7,000,000